Abstract:Objectives To understand the molecular features distinguishing anti-citrullinated protein antibodies (ACPA) from ‘conventional’ antibodies in rheumatoid arthritis (RA). Methods Serum of ACPA-positive RA patients was fractionated by size exclusion chromatography and analysed for the presence of ACPA-IgG by ELISA. ACPA-IgG and non-citrulline-specific IgG were affinity purified from serum, plasma and/or synovial fluid and analysed by gel electrophoresis. Electrophoresis bands were excised, enzymatically digested and analysed by mass spectrometry. Binding affinity to citrullinated antigens was measured by ELISA and imaging surface plasmon resonance using recombinant monoclonal ACPA with molecular modifications. Results In all donor samples studied (n=24), ACPA-IgG exhibited a 10–20 kDa higher molecular weight compared with non-autoreactive IgG. This feature also distinguished ACPA-IgG from antibodies against recall antigens or other disease-specific autoantibodies. Structural analysis revealed that a high frequency of N-glycans in the (hyper)variable domains of ACPA is responsible for this observation. In line with their localisation, these N-glycans were found to modulate binding avidity of ACPA to citrullinated antigens. Conclusions The vast majority of ACPA-IgG harbour N-glycans in their variable domains. As N-linked glycosylation requires glycosylation consensus sites in the protein sequence and as these are lacking in the ‘germline-counterparts’ of identified variable domains, our data indicate that the N-glycosylation sites in ACPA variable domains have been introduced by somatic hypermutation. This finding also suggests that ACPA-hyperglycosylation confers a selective advantage to ACPA-producing B cells. This unique and completely novel feature of the citrulline-specific immune response in RA elucidates our understanding of the underlying B cell response.

Changes of serum IgG glycosylation patterns in rheumatoid arthritis

A Method to Identify Trace Sulfated IgG N-glycans As Biomarkers for Rheumatoid Arthritis

An Integrated Proteomic and Glycoproteomic Study for Differences on Glycosylation Occupancy in Rheumatoid Arthritis

Abberant Immunoglobulin G Glycosylation in Rheumatoid Arthritis by LTQ-ESI-MS

Glycan Biomarkers for Rheumatoid Arthritis and Its Remission Status in Han Chinese Patients.

Distribution of Abnormal IgG Glycosylation Patterns from Rheumatoid Arthritis and Osteoarthritis Patients by MALDI-TOF-MSn

Changes in serum immunoglobulin G glycosylation patterns for antiphospholipid syndrome patients with lectin microarray

Integrative proteomics and N-glycoproteomics analyses of rheumatoid arthritis synovia reveal immune-associated glycopeptides

Serum IgG N-glycans Act As Novel Serum Biomarkers of Ankylosing Spondylitis

Serum IgG Glycan Hallmarks of Systemic Lupus Erythematosus

Antibody to Peptidoglycan Recognition Protein (PGLYRP)-2 As a Novel Biomarker in Rheumatoid Arthritis.

Altered Serum Metabolome is Associated with Disease Activity and Immune Responses in Rheumatoid Arthritis

Possible Role of Β-Galactosidase in Rheumatoid Arthritis

Glycobiology of rheumatic diseases

Serum Antigenome Profiling Reveals Diagnostic Models for Rheumatoid Arthritis

Alterations and diagnosis potential of serum lipid profiles in rheumatoid arthritis patients

The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia

Comprehensive analysis of glycoprotein profiles and their association with cardiovascular disease-related microRNAs in rheumatoid arthritis, metabolic disorders, and controls

Increased expression of alpha 1-antitrypsin,keratin type Ⅱ cuticular Hb4 and tubulin beta chain in the synovial tissues of patients with rheumatoid arthritis

Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis

Genome-Wide Mapping of Plasma IgG N-Glycan Quantitative Trait Loci Identifies a Potentially Causal Association between IgG N-Glycans and Rheumatoid Arthritis